H.C. Wainwright lowered the firm’s price target on CareDx (CDNA) to $25 from $26 and keeps a Neutral rating on the shares following the Q4 report.
Education
About Us
Working with TipRanks
Follow Us
1
H.C. Wainwright lowered the firm’s price target on CareDx (CDNA) to $25 from $26 and keeps a Neutral rating on the shares following the Q4 report.